Literature DB >> 17209061

X-linked gray platelet syndrome due to a GATA1 Arg216Gln mutation.

Venée N Tubman1, Jason E Levine, Dean R Campagna, Rita Monahan-Earley, Ann M Dvorak, Ellis J Neufeld, Mark D Fleming.   

Abstract

We identified a family with gray platelet syndrome (GPS) segregating as a sex-linked trait. Affected males had a mild bleeding disorder, thrombocytopenia, and large agranular platelets characteristic of GPS, while obligate carrier females were asymptomatic but had dimorphic platelets on peripheral smear. Associated findings included mild erythrocyte abnormalities in affected males. Linkage analysis revealed a 63 cM region on the X chromosome between markers G10578 and DXS6797, which segregated with the platelet phenotype and included the GATA1 gene. Sequencing of GATA1 revealed a G-to-A mutation at position 759 corresponding to amino acid change Arg216Gln. This mutation was previously described as a cause of X-linked thrombocytopenia with thalassemia (XLTT) but not of gray platelet syndrome. Our findings suggest that XLTT is within a spectrum of disorders constituting the gray platelet syndrome, and we propose that GATA1 is an upstream regulator of the genes required for platelet alpha-granule biogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17209061     DOI: 10.1182/blood-2006-02-004101

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  30 in total

1.  The α-granule proteome: novel proteins in normal and ghost granules in gray platelet syndrome.

Authors:  D M Maynard; H F G Heijnen; W A Gahl; M Gunay-Aygun
Journal:  J Thromb Haemost       Date:  2010-05-27       Impact factor: 5.824

2.  Analysis of disease-causing GATA1 mutations in murine gene complementation systems.

Authors:  Amy E Campbell; Lorna Wilkinson-White; Joel P Mackay; Jacqueline M Matthews; Gerd A Blobel
Journal:  Blood       Date:  2013-05-23       Impact factor: 22.113

Review 3.  Erythro-megakaryocytic transcription factors associated with hereditary anemia.

Authors:  John D Crispino; Mitchell J Weiss
Journal:  Blood       Date:  2014-03-20       Impact factor: 22.113

Review 4.  Normal and malignant megakaryopoiesis.

Authors:  Qiang Wen; Benjamin Goldenson; John D Crispino
Journal:  Expert Rev Mol Med       Date:  2011-10-21       Impact factor: 5.600

5.  Pleiotropic platelet defects in mice with disrupted FOG1-NuRD interaction.

Authors:  Yuhuan Wang; Ronghua Meng; Vincent Hayes; Rudy Fuentes; Xiang Yu; Charles S Abrams; Harry F G Heijnen; Gerd A Blobel; Michael S Marks; Mortimer Poncz
Journal:  Blood       Date:  2011-10-11       Impact factor: 22.113

6.  GATA1 Binding Kinetics on Conformation-Specific Binding Sites Elicit Differential Transcriptional Regulation.

Authors:  Atsushi Hasegawa; Hiroshi Kaneko; Daishi Ishihara; Masahiro Nakamura; Akira Watanabe; Masayuki Yamamoto; Cecelia D Trainor; Ritsuko Shimizu
Journal:  Mol Cell Biol       Date:  2016-07-29       Impact factor: 4.272

7.  Mechanism of platelet factor 4 (PF4) deficiency with RUNX1 haplodeficiency: RUNX1 is a transcriptional regulator of PF4.

Authors:  K Aneja; G Jalagadugula; G Mao; A Singh; A K Rao
Journal:  J Thromb Haemost       Date:  2011-02       Impact factor: 5.824

Review 8.  Inherited platelet disorders: thrombocytopenias and thrombocytopathies.

Authors:  Giovanna D'Andrea; Massimiliano Chetta; Maurizio Margaglione
Journal:  Blood Transfus       Date:  2009-10       Impact factor: 3.443

Review 9.  Inherited platelet dysfunction and hematopoietic transcription factor mutations.

Authors:  Natthapol Songdej; A Koneti Rao
Journal:  Platelets       Date:  2016-07-27       Impact factor: 3.862

Review 10.  Platelet alpha-granules: basic biology and clinical correlates.

Authors:  Price Blair; Robert Flaumenhaft
Journal:  Blood Rev       Date:  2009-05-17       Impact factor: 8.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.